Status:
UNKNOWN
Comparing Postoperative Pain Following COX-2 and Prostanoids Expression
Lead Sponsor:
Seoul National University Hospital
Conditions:
Female Genital Disease
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare postoperative pain following COX-2 and prostanoids expression in women who underwent laparoscopic surgery for female genital disease in order to evaluate the ef...
Detailed Description
In women who underwent laparoscopic surgery for female genital disease, the effect of COX-2 on local inflammation was assessed by randomization, using the COX-2 inhibitor celecoxib and placebo, compar...
Eligibility Criteria
Inclusion
- Female, Age ≥ 20 years
- Patients with benign female genital disease who need laparoscopic surgery
- Patients with benign disease who can be treated by single port laparoscopy
- Patients who signed an approved informed consent
Exclusion
- Female, Age \< 20 years
- Pregnancy
- Previous cancer history
- Patients who refuse to sign an informed consent
- Patients with benign female genital disease combined clinical peritonitis (ex. tubo-ovarian abscess, tubo-ovaritis, ruptured endometriosis)
- Patients with malignant female genital disease
- Patients who got surgery with multi-port laparoscopy
- Patients who are contraindicated with COX-2 inhibitors (liver disease, renal disease, active peptic ulcer, active gastrointestinal tract bleeding, ischemic heart disease, hyperkalemia)
Key Trial Info
Start Date :
October 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03391570
Start Date
October 17 2017
End Date
October 1 2019
Last Update
January 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea